Press releases
- Press releases
- Browse
Press releases
Three new licensing agreements in North America and three in Columbia More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
Sinclair Pharma plc announces today that Decapinol®, its oral rinse for the treatment of gingivitis (gum inflammation), has received registration approval from the FDA as a prescription medical device. More
Sinclair Pharma plc announces that Decapinol®, the company's oral rinse for the treatment and prevention of gingivitis has been launched in Italy, the product's first market More
Significant regulatory and commercial progress with 3 product approvals and 7 licensing deals More
Sinclair Pharma plc, the specialty pharmaceutical company, announces that it is today holding an R&D briefing in London for investors and analysts. More
Sinclair Pharma plc today announces three new licensing agreements, two for Atopiclair™ and the extension of an existing agreement for Aloclair® Rinse to include Aloclair® Spray. More
Sinclair Pharma plc announces that it has obtained EU registration for two new oral health products - Decapinol® Toothpaste and DecapiDecapinol® Gel More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Jun 2011 - 36 pages - $495
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us